Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache
- PMID: 35409644
- PMCID: PMC8997887
- DOI: 10.3390/ijerph19073961
Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache
Abstract
Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence is unknown. Methods (2): We conducted a case-control analysis nested in a prospective cohort study. Individuals were recruited from August 2020 to December 2020. Patients were grouped according to the presence or absence of long-COVID headache for three months after COVID-19 resolution. We compared demographic data, clinical variables, cardio-pulmonary laboratory biomarkers, quality of life, and cardio-pulmonary function between groups. Results (3): A cohort of 70 COVID-19 patients was evaluated. Patients with headaches (n = 10; 14.3%) were more frequently female (100% vs. 58.4%; p = 0.011) and younger (46.9 ± 8.45 vs. 56.13 ± 12 years; p = 0.023). No between-group differences in laboratory analysis, resting echocardiography, cardio-pulmonary exercise test, or pulmonary function tests were observed. Conclusion (4): In this exploratory study, no significant differences in cardio-pulmonary dysfunction were observed between patients with and without long-COVID headache during mid-term follow-up.
Keywords: COVID-19; cardio-pulmonary exercise testing; headache disorders; long-COVID syndrome.
Conflict of interest statement
The authors declare they have no actual or potential competing financial interests that are relevant to the content of this article.
References
-
- Trigo J., García-Azorín D., Planchuelo-Gómez Á., Martínez-Pías E., Talavera B., Hernández-Pérez I., Valle-Peñacoba G., Simón-Campo P., De Lera M., Chavarría-Miranda A., et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study. J. Headache Pain. 2020;21:94. doi: 10.1186/s10194-020-01165-8. - DOI - PMC - PubMed
-
- Caronna E., Ballvé A., Llauradó A., Gallardo V.J., Ariton D.M., Lallana S., Maza S.L., Gadea M.O., Quibus L., Restrepo J.L., et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410–1421. doi: 10.1177/0333102420965157. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous